Model Can Predict, Stratify Liver Cancer Risk in Noncirrhotic Chronic Hep B
New model exhibited satisfactory discrimination and calibration, with c-statistics of 0.844 and 0.813 in derivation, validation cohorts
Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients
Independent risk factors for CAC include older age, lower hemoglobin levels, hypertension, diabetes
Early, Virtual Palliative Care Feasible for Advanced Lung Cancer
Study shows similar effects on quality of life as in-person visits
Lactated Ringer Solution Better Than Normal Saline for Sickle Cell Pain Crises
Findings seen for patients receiving ≥2 L on day 1 of inpatient stay
Study Looks at Sex Differences in Melanoma Incidence
Melanoma incidence highest on trunk in men; incidence historically highest on limbs in women, but recent increases seen in truncal melanoma
AI Can Use ECG Images to Define Risk for Cancer Therapy-Linked Cardiac Dysfunction
In recent study, incidence of CTRCD and LVEF <40 percent were higher in association with high- versus low-risk AI ECG screen
Moderate Hypofractionation Shows Good Safety Outcomes in Breast Cancer
Safety profile, cosmesis, quality of life improved for MHF versus conventional fractionation
Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC
Findings seen in patients previously treated with platinum-based chemotherapy and immunotherapy whose tumors highly expressed CEACAM5
Risk for Venous Thromboembolism Up for Those With Sickle Cell Trait
Risk for pulmonary embolism was higher than that of isolated deep vein thrombosis in SCT
Perioperative Nivolumab Beneficial for Resectable NSCLC
Perioperative nivolumab showed event-free survival benefit from time of surgery compared with neoadjuvant nivolumab
